1. MiR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor. Issue 3 (4th October 2013) Authors: Pichler, Martin; Winter, Elke; Ress, Anna Lena; Bauernhofer, Thomas; Gerger, Armin; Kiesslich, Tobias; Lax, Sigurd; Samonigg, Hellmut; Hoefler, Gerald Journal: Journal of clinical pathology Issue: Volume 67:Issue 3(2014) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MiR‐96‐5p influences cellular growth and is associated with poor survival in colorectal cancer patients. Issue 11 (25th September 2014) Authors: Ress, Anna Lena; Stiegelbauer, Verena; Winter, Elke; Schwarzenbacher, Daniela; Kiesslich, Tobias; Lax, Sigurd; Jahn, Stefan; Deutsch, Alexander; Bauernhofer, Thomas; Ling, Hui; Samonigg, Hellmut; Gerger, Armin; Hoefler, Gerald; Pichler, Martin Journal: Molecular carcinogenesis Issue: Volume 54:Issue 11(2015:Nov.) Page Start: 1442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗